Panagiotis Tsourapas - 16 Sep 2026 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Sep 2026, 16:10:23 UTC
Prior SEC filing
15 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kristine Hutchinson, Attorney-in-Fact

Key filing fact

Panagiotis Tsourapas filed Form 4 for COLGATE PALMOLIVE CO (CL) on 18 Sep 2026.

Key facts

  • This page summarizes Panagiotis Tsourapas's Form 4 filing for COLGATE PALMOLIVE CO (CL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Sep 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 15 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001576945 Primary reporting owner

Tsourapas Panagiotis

Relationship
COO, CD, EMEA, APac, Skin
Address
C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Signature date
18 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CL transaction

Common Stock

Award

Transaction value
Shares
+4,597
Change %
+67%
Price
$0.000000*
Shares after
11,447
Date
16 Sep 2026
Ownership
Direct
Footnotes
F1
CL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,619
Date
16 Sep 2026
Ownership
By Issuer's 401(k) Plan Trustee
CL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
64,901
Date
16 Sep 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+31,814
Change %
Price
$0.000000*
Shares after
31,814
Date
16 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31,814
Exercise price
$87.02
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

Footnote F2

Stock option award granted under the issuer's incentive compensation plan.

Footnote F3

Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .